Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Change in Receivables: 2021-2025

Historic Change in Receivables for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to $545,000.

  • MDxHealth's Change in Receivables rose 173.95% to $545,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year increase of 81.67%. This contributed to the annual value of -$3.2 million for FY2024, which is 91.68% down from last year.
  • MDxHealth's Change in Receivables amounted to $545,000 in Q3 2025, which was up 2,170.83% from $24,000 recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Change in Receivables peaked at $545,000 during Q3 2025, and registered a low of -$4.8 million during Q3 2022.
  • For the 3-year period, MDxHealth's Change in Receivables averaged around -$625,857, with its median value being -$455,000 (2023).
  • Per our database at Business Quant, MDxHealth's Change in Receivables tumbled by 609.87% in 2022 and then surged by 173.95% in 2025.
  • MRQ analysis of 5 years shows MDxHealth's Change in Receivables stood at -$679,000 in 2021, then tumbled by 609.87% to -$4.8 million in 2022, then skyrocketed by 38.57% to -$3.0 million in 2023, then soared by 110.47% to $310,000 in 2024, then soared by 75.81% to $545,000 in 2025.
  • Its last three reported values are $545,000 in Q3 2025, $24,000 for Q2 2025, and -$1.1 million during Q1 2025.